Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Fluocinolone vs Mometasone Triple Creams for Melasma
NCT06780644Not yet recruiting
- Sponsor
- Universitas Indonesia
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of mometasone furoate nasal spray in melasma (2 arms), sponsored by Universitas Indonesia. Primary endpoints: modified Melasma Severity Index at 84 days, Patient's Tolerability Assessment at 84 days and 5 more. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
mometasone furoate nasal spray
03
Conditions
melasma
Beyond the preview
Go deeper on NCT06780644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06780644.